Callitas Health (Callitas Health) Total Inventories : $0.09 Mil (As of Sep. 2020)

View and export this data going back to 2008. Start your Free Trial

What is Callitas Health Total Inventories?

Callitas Health's total inventories for the quarter that ended in Sep. 2020 was $0.09 Mil. Callitas Health's average total inventories from the quarter that ended in Jun. 2020 to the quarter that ended in Sep. 2020 was $0.08 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Callitas Health's Net-Net Working Capital per share for the quarter that ended in Sep. 2020 was $-0.10.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Callitas Health's Days Inventory for the three months ended in Sep. 2020 was 367.40.

Inventory Turnover measures how fast the company turns over its inventory within a year. Callitas Health's Inventory Turnover for the quarter that ended in Sep. 2020 was 0.25.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Callitas Health's Inventory-to-Revenue for the quarter that ended in Sep. 2020 was 1.96.

Callitas Health Total Inventories Historical Data

The historical data trend for Callitas Health's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Callitas Health Total Inventories Chart

Callitas Health Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Total Inventories

Get a 7-Day Free Trial

0.09

0.01

Callitas Health Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Total Inventories	Get a 7-Day Free Trial															-	0.01	0.01	0.07	0.09

Callitas Health Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Callitas Health (OTCPK:MPHMF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Callitas Health's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2020 is

	Net-Net Working Capital Per Share (Q: Sep. 2020 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.017	+	0.75 * 0	+	0.5 * 0.086	-	4.537
-	0	-	0)	/	45.272
=	-0.10

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Callitas Health's Days Inventory for the three months ended in Sep. 2020 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Sep. 2020 )	/	Cost of Goods Sold (Q: Sep. 2020 )	*	Days in Period
	=	0.0765	/	0.019	*	365 / 4
	=	367.40

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Callitas Health's Inventory Turnover for the quarter that ended in Sep. 2020 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Sep. 2020 )	/	Average Total Inventories (Q: Sep. 2020 )
	=	0.019	/	0.0765
	=	0.25

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Callitas Health's Inventory to Revenue for the quarter that ended in Sep. 2020 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Sep. 2020 )	/	Revenue (Q: Sep. 2020 )
	=	0.0765	/	0.039
	=	1.96

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Callitas Health Total Inventories Related Terms

Thank you for viewing the detailed overview of Callitas Health's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Callitas Health (Callitas Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Callitas Health Inc (OTCPK:MPHMF) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

734 - 1055 Dunsmuir Street, Vancouver, BC, CAN, V7X 1B1

Website

http://www.callitas.com

Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.